|
MAP3K1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.765300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.720400E-03 |
| Normal-vs-Stage2 |
8.396200E-02 |
| Normal-vs-Stage3 |
2.477800E-01 |
| Normal-vs-Stage4 |
4.655000E-01 |
| Stage1-vs-Stage2 |
3.631600E-01 |
| Stage1-vs-Stage3 |
3.595600E-01 |
| Stage1-vs-Stage4 |
2.479000E-01 |
| Stage2-vs-Stage3 |
2.602200E-01 |
| Stage2-vs-Stage4 |
2.025800E-01 |
| Stage3-vs-Stage4 |
7.994400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.301300E-03 |
| Normal-vs-AfricanAmerican |
2.850200E-02 |
| Normal-vs-Asian |
9.591000E-01 |
| Caucasian-vs-AfricanAmerican |
9.597000E-01 |
| Caucasian-vs-Asian |
3.901000E-01 |
| AfricanAmerican-vs-Asian |
3.973600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.758400E-03 |
| Normal-vs-Female |
1.758080E-03 |
| Male-vs-Female |
1.741820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.080840E-01 |
| Normal-vs-Extreme_Weight |
2.699600E-02 |
| Normal-vs-Obese |
8.663400E-03 |
| Normal-vs-Extreme_Obese |
9.495600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.788600E-01 |
| Normal_Weight-vs-Obese |
5.325000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.719200E-01 |
| Extreme_Weight-vs-Obese |
5.734000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.109000E-01 |
| Obese-vs-Extreme_Obese |
1.922790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.902400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.426690E-04 |
| Normal-vs-Age(61-80Yrs) |
2.587600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.942200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.753600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.557200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.976000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.424000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.257100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.766590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.55710999999448E-05 |
| Normal-VS-Type2 PRCC |
5.610200E-01 |
| Normal-VS-KIRP CIMP |
2.866600E-01 |
| Normal-VS-Unclassified PRCC |
1.284110E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.21070000480961E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.651750E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.427000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.212000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.584500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.111410E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.675800E-01 |
| Normal-vs-N1 |
9.083800E-02 |
| Normal-vs-N2 |
2.430200E-01 |
| N0-vs-N1 |
1.550570E-01 |
| N0-vs-N2 |
5.379200E-01 |
| N1-vs-N2 |
5.089000E-01 |
|
|
